IL112097A - N- (POLYHYDRO- OXACYCLOALKANO £2, 3-g| INDOL-1-YLALKYL) (CYCLO) ALKANANILIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents
N- (POLYHYDRO- OXACYCLOALKANO £2, 3-g| INDOL-1-YLALKYL) (CYCLO) ALKANANILIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEMInfo
- Publication number
- IL112097A IL112097A IL112097A IL11209794A IL112097A IL 112097 A IL112097 A IL 112097A IL 112097 A IL112097 A IL 112097A IL 11209794 A IL11209794 A IL 11209794A IL 112097 A IL112097 A IL 112097A
- Authority
- IL
- Israel
- Prior art keywords
- formula
- compound
- compounds
- pharmaceutically acceptable
- mixture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939326192A GB9326192D0 (en) | 1993-12-22 | 1993-12-22 | Chemical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL112097A0 IL112097A0 (en) | 1995-03-15 |
| IL112097A true IL112097A (en) | 1998-06-15 |
Family
ID=10747030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL112097A IL112097A (en) | 1993-12-22 | 1994-12-21 | N- (POLYHYDRO- OXACYCLOALKANO £2, 3-g| INDOL-1-YLALKYL) (CYCLO) ALKANANILIDES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5633276A (cs) |
| EP (1) | EP0736028A1 (cs) |
| JP (1) | JPH09507057A (cs) |
| AP (1) | AP535A (cs) |
| AU (1) | AU684877B2 (cs) |
| CA (1) | CA2179402A1 (cs) |
| CO (1) | CO4340623A1 (cs) |
| GB (1) | GB9326192D0 (cs) |
| IL (1) | IL112097A (cs) |
| IS (1) | IS4244A (cs) |
| MY (1) | MY131641A (cs) |
| SV (1) | SV1994000083A (cs) |
| TW (1) | TW291479B (cs) |
| WO (1) | WO1995017405A1 (cs) |
| ZA (1) | ZA9410056B (cs) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2741799B1 (fr) * | 1995-12-04 | 1998-01-02 | Oreal | Utilisation de melatonine dans une composition pour traiter les signes cutanes des etats de fatigue |
| US6034239A (en) * | 1996-03-08 | 2000-03-07 | Takeda Chemical Industries, Ltd. | Tricyclic compounds, their production and use |
| EP1199304A1 (en) * | 1997-03-05 | 2002-04-24 | Takeda Chemical Industries, Ltd. | Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders |
| HU224220B1 (hu) * | 1996-03-08 | 2005-06-28 | Takeda Pharmaceutical Company Limited | Triciklusos vegyületek, eljárás előállításukra és alkalmazásuk |
| EP1027043B1 (en) * | 1996-12-10 | 2004-11-10 | Bristol-Myers Squibb Company | Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents |
| US5948817A (en) * | 1997-03-05 | 1999-09-07 | Bristol-Myers Squibb Company | Polycyclic ethyl alkylamide melatonergic agents |
| FR2763335B1 (fr) * | 1997-05-16 | 2000-11-24 | Adir | Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| AU727654B2 (en) * | 1997-06-13 | 2000-12-21 | Yamanouchi Pharmaceutical Co., Ltd. | Tricyclic pyrazole derivative |
| US6214869B1 (en) | 1998-06-05 | 2001-04-10 | Bristol-Myers Squibb | Heterocyclic cis cyclopropane derivatives as melatonergic agents |
| ATE257834T1 (de) | 1999-06-30 | 2004-01-15 | Bristol Myers Squibb Co | Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe |
| GB9918965D0 (en) * | 1999-08-11 | 1999-10-13 | Cerebrus Ltd | Chemical compounds xxi |
| AU6595000A (en) | 1999-08-20 | 2001-03-19 | Takeda Chemical Industries Ltd. | Dihydrobenzofuran derivatives, process for the preparation thereof and agents |
| US7012090B1 (en) | 2000-03-17 | 2006-03-14 | Alcon, Inc. | Pyranoindoles for treating glaucoma |
| MXPA02008294A (es) * | 2000-03-17 | 2002-12-09 | Alcon Inc | Piranoindoles para el tratamiento del glaucoma. |
| ES2172415B2 (es) | 2000-07-28 | 2003-11-16 | Univ Madrid Complutense | Tratamiento del glaucoma y la hipertension ocular por medio de un analogo de la melatonina. |
| US6743448B2 (en) * | 2000-12-11 | 2004-06-01 | Abraham H. Kryger | Topical testosterone formulations and associated methods |
| US20030096379A1 (en) * | 2001-03-28 | 2003-05-22 | Kilgore James L. | Method for producing tryptamine derivatives |
| AU2007228087A1 (en) * | 2006-03-20 | 2007-09-27 | Takeda Pharmaceutical Company Limited | Agent for prevention/treatment of irritable bowel syndrome |
| JP5227806B2 (ja) * | 2006-12-08 | 2013-07-03 | 武田薬品工業株式会社 | 三環性化合物およびその医薬用途 |
| ES2331274B1 (es) * | 2007-10-25 | 2010-10-21 | Ferrer Internacional, S.A. | Compuesto de indolina. |
| EP2350088A1 (en) * | 2008-07-30 | 2011-08-03 | Ferrer Internacional, S.A. | 1,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds |
| BR102016024814A2 (pt) | 2016-10-24 | 2018-05-08 | Aché Laboratórios Farmacêuticos S.A. | composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2485539A1 (fr) * | 1980-06-26 | 1981-12-31 | Sori Soc Rech Ind | Nouveau derive de pyranno-indole, son procede de preparation et son application en therapeutique |
| US4738972A (en) * | 1985-05-21 | 1988-04-19 | Pfizer Inc. | Hypoglycemic thiazolidinediones |
| WO1986007056A1 (en) * | 1985-05-21 | 1986-12-04 | Pfizer Inc. | Hypoglycemic thiazolidinediones |
-
1993
- 1993-12-22 GB GB939326192A patent/GB9326192D0/en active Pending
-
1994
- 1994-12-08 TW TW083111439A patent/TW291479B/zh active
- 1994-12-16 IS IS4244A patent/IS4244A/is unknown
- 1994-12-19 ZA ZA9410056A patent/ZA9410056B/xx unknown
- 1994-12-19 MY MYPI94003410A patent/MY131641A/en unknown
- 1994-12-20 WO PCT/EP1994/004220 patent/WO1995017405A1/en not_active Ceased
- 1994-12-20 JP JP7517174A patent/JPH09507057A/ja active Pending
- 1994-12-20 AU AU12743/95A patent/AU684877B2/en not_active Ceased
- 1994-12-20 US US08/652,460 patent/US5633276A/en not_active Expired - Fee Related
- 1994-12-20 EP EP95903817A patent/EP0736028A1/en not_active Ceased
- 1994-12-20 CA CA002179402A patent/CA2179402A1/en not_active Abandoned
- 1994-12-20 AP APAP/P/1994/000706A patent/AP535A/en active
- 1994-12-21 IL IL112097A patent/IL112097A/en not_active IP Right Cessation
- 1994-12-21 CO CO94057739A patent/CO4340623A1/es unknown
- 1994-12-21 SV SV1994000083A patent/SV1994000083A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MY131641A (en) | 2007-08-30 |
| GB9326192D0 (en) | 1994-02-23 |
| SV1994000083A (es) | 1995-07-24 |
| AP9400706A0 (en) | 1995-01-31 |
| EP0736028A1 (en) | 1996-10-09 |
| ZA9410056B (en) | 1995-10-18 |
| CA2179402A1 (en) | 1995-06-29 |
| US5633276A (en) | 1997-05-27 |
| WO1995017405A1 (en) | 1995-06-29 |
| JPH09507057A (ja) | 1997-07-15 |
| CO4340623A1 (es) | 1996-07-30 |
| AP535A (en) | 1996-09-16 |
| TW291479B (cs) | 1996-11-21 |
| AU684877B2 (en) | 1998-01-08 |
| IL112097A0 (en) | 1995-03-15 |
| AU1274395A (en) | 1995-07-10 |
| IS4244A (is) | 1995-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP535A (en) | Indoline derivatives, method of preparation and use. | |
| JP2941309B2 (ja) | 化合物 | |
| JP3033076B2 (ja) | カンナビノイド受容体への親和性を有するインドール誘導体 | |
| US8138187B2 (en) | Substituted heteroaryl derivatives | |
| US5981572A (en) | Benzofurans and benzopyrans as chronobiological agents | |
| EP0690843B1 (en) | Formyl- or cyano- substituted indole derivatives having dopaminergic activity | |
| EP0219193B1 (en) | Tetrahydrocarbazolone derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| SE452460B (sv) | 3-/2-(dimetylamino)etyl/-n-metyl-1h-indol-5-metansulfonamid, en farmaceutisk komposition innehallande denna och ett forfarande for framstellning av foreningen | |
| JPH10508297A (ja) | ニューロキニンアンタゴニストとしての置換アリールピペラジン | |
| US7060710B2 (en) | Isoxazole pyrazoloindane derivatives as cognition enhancing GABAA α5 subtype ligands | |
| JP2000510153A (ja) | スピロ―ピペリジン誘導体及び該誘導体の治療薬としての使用 | |
| LU85743A1 (fr) | Composes heterocycliques | |
| JPS6277383A (ja) | 複素環式化合物 | |
| WO1999011619A1 (en) | Phenylindole derivatives as 5-ht2a receptor ligands | |
| JPH10502336A (ja) | ナフタレン誘導体、製造方法および使用 | |
| CH667454A5 (fr) | Derives d'indoles. | |
| JP2941333B2 (ja) | インドール誘導体 | |
| BRPI0418306B1 (pt) | composto n-[(1s,1ar,7br)-4,7-difluoro-1,1a,2,7b-tetraidrociclopropa[c]cromen-1-il]-n’-[5-(4-(sulfonamido)fenoxi)-2-piridinil]ureia, composição farmacêutica e uso do dito composto para profilaxia ou tratamento de infecções por hiv-1 | |
| JPH09512034A (ja) | 5ht1−様作動薬としてのインドール誘導体 | |
| JP2791069B2 (ja) | シクロオクタン神経保護剤 | |
| JPH10101644A (ja) | 松果体ホルモン作用薬 | |
| KR20000011021A (ko) | 시간생물학적 제제인 벤조푸란 및 벤조피란 | |
| JPS62270581A (ja) | 3−ジフエニル置換オクタヒドロインドリジン鎮痛性化合物 | |
| JPH0443915B2 (cs) | ||
| HK1018901B (en) | Benzofurans and benzopyrans as chronobiological agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| MM9K | Patent not in force due to non-payment of renewal fees |